TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Howley, Simone Lead Cancer Policy Board: AMA Campaign Fights Youth Smoking November 22, 1996
TCL Archive In Brief: Henderson Names to HHA Post; Nurses Support Cigarette Tax Increase; FDA Staff Changes May 7, 1993
